The University of California, Santa Barbara will receive a $3.2 million grant from the California Institute for Regenerative Medicine to develop a state-of-the-art stem cell research facility. The center aims to foster interdisciplinary research and translation of stem cell-based therapeutics for human diseases.
Scientists at UCLA have successfully differentiated induced pluripotent stem cells (iPS cells) into three types of cardiovascular cells, including cardiomyocytes, endothelial cells, and vascular smooth muscle cells. This discovery could potentially lead to new therapies for heart attacks, atherosclerosis, and other cardiovascular disea...
Researchers identified adult stem cells in the pituitary gland of mice that can adapt to traumatic stress or normal life changes. These cells are distinct from embryonic stem cells and have a more limited repertoire, but still play a crucial role in maintaining the organ's function.
Researchers at University Medical Center Utrecht have successfully grown large numbers of stem cells from adult human hearts into new heart muscle cells. The stem cells can be used to study cardiac arrhythmia, test new medicines, and potentially repair damaged heart tissue. This breakthrough in stem cell research could move forward res...
Researchers have identified and cloned ovarian cancer stem cells, which may be the source of recurrence and resistance to chemotherapy. These stem cells can replicate indefinitely and are highly resistant to conventional treatment.
Recent discoveries suggest that stem cells can serve as potential therapeutic targets for many types of cancers. Researchers have identified specific markers, such as aldehyde dehydrogenase, to isolate cancer-initiating cells and track their response to treatment. These findings hold promise for the development of targeted therapies.
Researchers aim to understand the mechanisms that regulate stem cell function, which may contribute to malignant brain tumor formation. The study finds similarities in stem cell regulation and cancer tumor maintenance, potentially paving the way for targeted therapies.
Researchers have found that a key gene called Apc plays a crucial role in controlling adult stem cells and preventing tumours. The study suggests that when this gene is lost or damaged, the normal function of adult stem cells breaks down, leading to cancer. This research has important implications for using adult stem cells for therapy.
Researchers at Stanford University School of Medicine have successfully created cancer stem cells in a laboratory setting, shedding new light on the origins of these rare and difficult-to-study cells. The breakthrough could lead to new ways of understanding how cancer cells form and developing more effective treatments.
Dame Anne McLaren was a pioneer in embryonic germ cells and contributed to IVF treatments. Prof Christine Mummery will honor her memory with a keynote lecture on advances in stem cell research, highlighting its potential for treating diseases like heart damage.
A team of scientists at the Joslin Diabetes Center has identified a key regulator of hematopoietic stem cell migration and proliferation, which could lead to improved bone marrow and blood cell transplants. The discovery also holds promise for treating type 1 diabetes and enhancing recovery from infections after transplantation.
New study finds blood-forming stem cells can survive without Notch signals, allaying fears of damage during chemotherapy. The findings have implications for a high-profile breast-cancer drug trial combining chemotherapy with a Notch inhibitor.
Researchers found a shared genetic expression pattern between embryonic stem cells and human cancer cells, which may have significant implications for cancer therapeutics. A gene module map was created to relate transcriptional programs in different cell types.
Scientists have discovered a way to genetically manipulate embryonic stem cells into insulin-producing pancreatic tissue, potentially treating type-1 and type-2 diabetes. The team found that the transcription factor PAX4 encouraged high numbers of stem cells to become beta cells with insulin-producing capabilities.
A study published in Nature reveals that the protein REST maintains self-renewal and pluripotency in embryonic stem cells by suppressing a specific microRNA called miR-21. This discovery has implications for regenerative medicine and treating diseases, including pediatric brain cancer.
Researchers have made a groundbreaking discovery about the origin of blood stem cells, finding that they are generated in the placenta. The study's findings may allow for the growth of blood stem cells in cell culture, potentially leading to new treatments for diseases like leukemia and aplastic anemia. By understanding how blood stem ...
Recent research suggests adult stem cells from blood or marrow may provide treatment benefits for certain autoimmune diseases and cardiovascular disorders. The studies indicate that these cells can contribute to modest improvement in cardiac function, but more clinical trials are needed to determine their effectiveness.
Researchers use bioengineering techniques to create functional adult-like cells from embryonic stem cells and adult blood stem cells, paving the way for new medical treatments
UCLA stem cell scientists have successfully reprogrammed human skin cells into embryonic stem cells without using embryos or eggs. This breakthrough uses genetic alteration to turn back the clock on human skin cells and create cells nearly identical to human embryonic stem cells, which can become every cell type in the human body.
A recent study from Rockefeller University has discovered the protein NFATc1, which regulates hair growth and maintains stem cell potency. The research suggests that these stem cells do not need prolonged resting periods to maintain their abilities.
The Xie Lab found that Drosophila ovarian germline stem cells can out-compete normal stem cells for a position in the niche by invading neighboring cells and increasing cellular response to E-cadherin. This mechanism ensures only undifferentiated stem cells remain in the niche.
Researchers found that cancer stem cells are stuck at an early developmental stage due to epigenetic repression of BMPR1B, leading to aberrant cell division and tumor growth. Forced expression of silenced BMPR1B restored normal differentiation capacity, offering new therapeutic approaches for glioma patients.
UCI researchers have found a novel method to sort stem cells based on their electric charges, which could expedite therapies for conditions like Alzheimer's and Parkinson's diseases. The technique uses electrodes on a tiny glass slide and has the potential to be more cost-effective and quicker than current methods.
Researchers discovered a genetic switch that regulates critical properties of cancer stem cells using microRNAs. Activating this switch, let-7, can push cancer stem cells to differentiate and lose their tumorigenic abilities, offering a novel approach to targeting these cells with therapeutic RNAs.
Researchers have successfully transferred a new gene to cancer patients via their own stem cells, aiming for stronger treatment with less severe side effects. The study found that six out of eight patients had stem cells carrying the MGMT gene in their blood or bone marrow after treatment.
Researchers used PET imaging and bioluminescence to track stem cell behavior in small animal models, determining their fate and potential applications in treating heart diseases, brain disorders, and cancer. The unique combination of these imaging techniques offers a reliable method for labeling stem cells.
A new marker, ALDH1, has been identified that can be used to detect and characterize cancer stem cells in breast tumors. These cells are responsible for fueling a tumor's growth and are linked to worse outcomes.
A recent study by MIT scientists suggests that adult stem cells produced in the brain can only make limited connections, making it challenging to use them for replacement therapy. The research calls into question the potential of using adult stem cells to repair damaged brain tissue and replace lost neurons.
Researchers at UW-Madison have successfully reprogrammed skin cells into embryonic stem cells, potentially resolving the ethical controversy surrounding human embryonic stem cell research. This breakthrough could lead to a shift in government funding policies and pave the way for non-embryonic stem cell research.
Researchers have discovered a way to transform adult human skin cells into cells resembling embryonic stem cells, which can differentiate into various tissue types. The converted cells display physical and genetic features similar to those found in embryonic stem cells.
A team of University of Wisconsin-Madison researchers successfully reprogrammed human skin cells into cells indistinguishable from embryonic stem cells. This breakthrough could revolutionize the field of stem cell biology and provide a new source of stem cells for medical research.
Acclaimed stem cell researcher Shinya Yamanaka successfully reprograms human adult cells into pluripotent stem cells capable of developing into any cell type. This breakthrough accelerates the pace of stem cell research and holds promise for generating alternative sources of human pluripotent stem cells.
Researchers have discovered that human embryonic stem cell nuclei are the most deformable, followed by hematopoietic stem cells, which generate blood and tissue cells. The study reveals that lamin proteins play a key role in stabilizing the nucleus and controlling gene expression.
Researchers have found that adult stem cells do not rely on the protein Oct4 to remain undifferentiated. Studies using sensitive assays failed to detect Oct4 in these cells, revealing a different regulation of pluripotency in adult versus embryonic stem cells.
The Stowers Institute's Xie Lab has discovered that stem cell aging is controlled by both intrinsic and extrinsic factors. The study found that specific proteins, adhesion between cells, and enzyme activity can influence stem cell lifespan and function, potentially leading to the development of new therapies for age-related diseases.
The study found that aging stem cells in fruit flies experienced a decline in growth factor unpaired (upd), leading to reduced stem cell numbers. Artificially increasing upd levels delayed the loss of germline stem cells, suggesting that the niche's molecular signals govern stem cell behavior.
A study reveals a new mechanism controlling how stem cells become either skeletal or smooth muscle cells, with implications for treating heart disease and cancer. The discovery of myocardin suggests new ways to treat diseases driven by stem cell replacement programs.
Researchers from Weill Cornell Medical College report a breakthrough in isolating specialized subsets of spermatogonial stem cells that can generate a wide range of cell and tissue types. The study's findings have promising implications for regenerative medicine, offering an alternative to embryonic stem cells.
Scientists have successfully reprogrammed adult stem cells from male mice' testes into functional blood vessels and cardiac tissue. These multipotent adult spermatogonial-derived stem cells may offer an alternative to embryonic stem cells without ethical concerns.
Researchers created methods to study millions of stem cells on devices the size of a microscope slide, enabling thousands of individual stem cell experiments to be carried out quickly. A platform was also developed to understand how different genes impact stem cell function or development, allowing for rapid screening of genetic sequen...
The new journal Stem Cell Research will cover all aspects of stem cell research, including embryonic stem cells, cancer stem cells, and developmental studies. It aims to disseminate the results of ongoing research in this rapidly expanding field, with a focus on high-quality peer-reviewed studies.
A UCR plant cell biologist is studying how plant stem cells maintain their identity and specialize into different cell types. He will use two powerful methods, microgenomics and live imaging, to understand the molecular and cellular mechanisms behind stem-cell regulation.
Researchers at University of Michigan dispute the immortal strand hypothesis, which suggests adult stem cells minimize genetic mutations through a non-random DNA segregation process. They found no evidence supporting this idea in blood-forming mouse stem cells.
Researchers developed a method to create cardiac muscle cells from embryonic stem cells, which then survived and thrived in damaged rat hearts. The treatment showed promise in improving heart function and thickness of walls after a heart attack.
Researchers identified a protein signal that prevents neural stem cells from becoming neurons, shedding light on the maturation process of stem cells. The discovery could simplify stem cell isolation and potentially have implications for treating nervous system damage.
Researchers at Boston Children's Hospital and the Harvard Stem Cell Institute used genetic techniques to compare embryonic stem cells from different sources. They discovered that parthenogenetic embryonic stem cells have a distinct genetic signature reflecting their biological origins, setting the historical record straight for a now-d...
A University of Michigan study has identified the Sox17 gene, which regulates blood-forming fetal stem cells. The discovery may lead to new insights into childhood leukemias and the development of bone marrow transplantation from human embryonic stem cells.
Scientists at McMaster University have made a groundbreaking discovery about human embryonic stem cells, finding they can generate fuel to sustain themselves. This breakthrough has significant implications for future clinical therapy, as it could lead to the development of new treatments for diseases such as Parkinson's and diabetes.
Researchers found that transplanted stem cells triggered the brain's self-repair mechanisms by boosting nerve survival and blood vessel development. The study suggests that stem cells may be more effective at repairing damaged brain tissue than previously thought.
A $2.5M NIH grant supports research using adult stem cells to engineer soft tissue for facial reconstruction after injuries or surgery. The Columbia University team aims to develop a process that allows patients to use their own stem cells to create long-lasting implants.
A team of Canadian scientists has identified 1,155 genes under the control of Oct4, a master regulator of the stem cell state. These genes help maintain stem cells in a flexible state by controlling DNA packaging, cell division, and signaling pathways.
Research at the University of Pittsburgh School of Medicine suggests that chemotherapy must target a subset of cancer stem cells to be effective in treating lung cancers. Cancer stem cells, similar to normal stem cells, can resist multiple drug resistance transporters, making them resistant to conventional therapies.
A breast cancer cell line has been found to behave like cancer stem cells, allowing researchers to study the dynamics of cancer stem cells in tissue. This breakthrough could lead to targeted treatments for breast cancer by specifically targeting cancer stem cells for destruction while leaving normal stem cells intact.
Researchers successfully induced pluripotent cells from fibroblasts using four transcription factors, exhibiting properties similar to embryonic stem cells. These findings have significant implications for regenerative medicine and may pave the way for generating patient-specific stem cell lines directly from a person's own cells.
Researchers at UCLA successfully reprogrammed normal tissue cells into cells with unlimited properties as embryonic stem cells, offering a promising alternative to current cloning methods. The breakthrough could lead to the creation of immune-compatible cells for disease treatment and regenerative therapies.
Researchers at Whitehead Institute successfully reprogrammed mature skin cells into pluripotent cells, identical to embryonic stem cells, without using eggs or destroying embryos. These cells can give rise to live mice and transmit their genetic material to subsequent generations.
UCI will receive $3.9 million to enhance its core embryonic stem cell research laboratory and expand a training program for young scientists on research techniques involving human embryonic stem cells. The grant is part of $50 million in funding awarded to 17 institutions by the California Institute for Regenerative Medicine.
Researchers at Stanford University School of Medicine have identified cancer stem cells in colorectal tumors, which can propagate and maintain the growth of the tumor. These stem cells have been found to be responsible for the spread of cancer to distant sites and are likely to be responsible when tumors resurface or spread.
A new study from Harvard Medical School identifies p63 as the master regulator of epithelial stem cells, which are essential for tissue regeneration and have implications for cancers such as breast, prostate, and skin. The findings show that p63 imparts 'stemness' to regenerative cells, maintaining a steady pool of these cells.
Researchers have discovered a new mechanism by which adult stem/progenitor cells enhance tissue repair in damaged organs. These cells not only differentiate into replacement cells but also stimulate the proliferation of existing stem cells and transfer mitochondrial DNA to dysfunctional cells.